Tenaya Therapeutics (TNYA) Other Accumulated Expenses (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Other Accumulated Expenses came in at $455000.0 in Q1 2026, up 30.0% year-on-year from $350000.0 in Q1 2025, and up 158.52% quarter-over-quarter from $176000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $455000.0 for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses rose 30.0% year-over-year to $455000.0 in Q1 2026; TTM through Mar 2026 was $455000.0, a 30.0% increase from a year earlier, with the FY2025 full-year figure at $176000.0, down 17.76% from the prior year.
- Other Accumulated Expenses improved to $455000.0 in Q1 2026 per TNYA's latest filing, from $176000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $833000.0 in Q1 2024 and bottomed at $142000.0 in Q2 2025.
- The 5-year median for Other Accumulated Expenses is $458000.0 (2023), against an average of $463117.6.
- Across the five-year window, Other Accumulated Expenses jumped 236.42% in 2022 and plunged 63.75% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $545000.0 in 2022, then fell by 12.29% to $478000.0 in 2023, then plunged by 55.23% to $214000.0 in 2024, then decreased by 17.76% to $176000.0 in 2025, then jumped by 158.52% to $455000.0 in 2026.
- Per Business Quant, the three latest TNYA Other Accumulated Expenses figures stand at $455000.0 (Q1 2026), $176000.0 (Q4 2025), and $186000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tenaya Therapeutics | 166.70 Mn | 166.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | 478,000.00 |
| Sep 30, 2023 | 458,000.00 |
| Jun 30, 2023 | 778,000.00 |
| Mar 31, 2023 | 677,000.00 |
| Dec 31, 2022 | 545,000.00 |
| Sep 30, 2022 | 485,000.00 |
| Jun 30, 2022 | 588,000.00 |
| Mar 31, 2022 | 791,000.00 |
| Dec 31, 2021 | 162,000.00 |
| Sep 30, 2021 | 514,000.00 |
| Jun 30, 2021 | 200,000.00 |